Cargando…

Regional cortical thickness in relapsing remitting multiple sclerosis: A multi-center study()

A comprehensive analysis of the global and regional values of cortical thickness based on 3D magnetic resonance images was performed on 250 relapsing remitting multiple sclerosis (MS) patients who participated in a multi-center, randomized, phase III clinical trial (the CombiRx Trial) and 125 normal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Narayana, Ponnada A., Govindarajan, Koushik A., Goel, Priya, Datta, Sushmita, Lincoln, John A., Cofield, Stacy S., Cutter, Gary R., Lublin, Fred D., Wolinsky, Jerry S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777814/ https://www.ncbi.nlm.nih.gov/pubmed/24179765 http://dx.doi.org/10.1016/j.nicl.2012.11.009

Ejemplares similares

Regional Gray Matter Atrophy in Relapsing Remitting Multiple Sclerosis: Baseline Analysis of Multi-Center Data
por: Datta, Sushmita, et al.
Publicado: (2015)

The Effect of Body Mass Index on Brain Volume and Cognitive Function in Relapsing–Remitting Multiple sclerosis: A CombiRx Secondary Analysis
por: Ben-Zacharia, Aliza Bitton, et al.
Publicado: (2021)

Relapse recovery in relapsing–remitting multiple sclerosis: An analysis of the CombiRx dataset
por: Koch, Marcus W, et al.
Publicado: (2023)

Effect of Intrinsic and Extrinsic Factors on Global and Regional Cortical Thickness
por: Govindarajan, Koushik A., et al.
Publicado: (2014)

Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial
por: Cutter, Gary, et al.
Publicado: (2023)

A comprehensive approach to the segmentation of multichannel three-dimensional MR brain images in multiple sclerosis()
por: Datta, Sushmita, et al.
Publicado: (2013)

The Neurocognitive and MRI Outcomes of West Nile Virus Infection: Preliminary Analysis Using an External Control Group
por: Murray, Kristy O., et al.
Publicado: (2018)

Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial
por: Weinstock-Guttman, Bianca, et al.
Publicado: (2021)

Cortical thickness abnormalities in long-term remitted Cushing’s disease
por: Bauduin, S. E. E. C., et al.
Publicado: (2020)

Cortical thickness abnormalities in long-term remitted cushing’s disease
por: Bauduin, S., et al.
Publicado: (2021)

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
por: Fleischer, Vinzenz, et al.
Publicado: (2019)

Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree
por: Cutter, Gary R., et al.
Publicado: (2016)

Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing‐remitting multiple sclerosis
por: Langdon, Dawn W., et al.
Publicado: (2021)

Comprehensive Brain MRI Segmentation in High Risk Preterm Newborns
por: Yu, Xintian, et al.
Publicado: (2010)

No Evidence of Disease Activity: Indirect Comparisons of Oral Therapies for the Treatment of Relapsing–Remitting Multiple Sclerosis
por: Nixon, Richard, et al.
Publicado: (2014)

Relapsing experimental allergic encephalomyelitis an autoimmune model of multiple sclerosis
por: Lublin, Fred D.
Publicado: (1985)

Cortical Excitability and Interhemispheric Connectivity in Early Relapsing–Remitting Multiple Sclerosis Studied With TMS-EEG
por: Zipser, Carl M., et al.
Publicado: (2018)

Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use
por: O’Connor, Paul W., et al.
Publicado: (2013)

Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study
por: Bar-Or, Amit, et al.
Publicado: (2018)

Relapsing/remitting type 1 diabetes
por: van Megen, Kayleigh M., et al.
Publicado: (2017)

Balance Changes in Patients With Relapsing-Remitting Multiple Sclerosis: A Pilot Study Comparing the Dynamics of the Relapse and Remitting Phases
por: Findling, Oliver, et al.
Publicado: (2018)

Cortical Shape and Curvedness Analysis of Structural Deficits in Remitting and Non-Remitting Depression
por: Liao, Yuan-Lin, et al.
Publicado: (2013)

Relapsing–remitting painful ophthalmoplegia due to orbital myositis
por: Guaschino, E., et al.
Publicado: (2005)

Pattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing–remitting MS
por: Stellmann, Jan‐Patrick, et al.
Publicado: (2016)

A Case of Relapsing-Remitting Tumefactive Demyelination
por: Wadhwa, Ankur, et al.
Publicado: (2019)

Relapsing and remitting viral diseases of the nervous system
por: Johnson, Richard T.
Publicado: (1984)

Endocarditis following ocrelizumab in relapsing-remitting MS
por: Faissner, Simon, et al.
Publicado: (2020)

Postural Control in Relapsing-Remitting Multiple Sclerosis
por: Cusin, Flavia Salvaterra, et al.
Publicado: (2022)

Systematic review of prediction models in relapsing remitting multiple sclerosis
por: Brown, Fraser S., et al.
Publicado: (2020)

Cerebellar Information Processing in Relapsing-Remitting Multiple Sclerosis (RRMS)
por: Lesage, E., et al.
Publicado: (2010)

Characterization of Remitting and Relapsing Hyperglycemia in Post-Renal-Transplant Recipients
por: Boloori, Alireza, et al.
Publicado: (2015)

Screening of dysphagia in relapsing-remitting multiple sclerosis patients in Montenegro
por: Eraković, Jevto Lj., et al.
Publicado: (2021)

Microscopic polyangiitis after alemtuzumab treatment in relapsing-remitting MS
por: Sauer, Eva-Maria, et al.
Publicado: (2018)

Pilot study of a ketogenic diet in relapsing-remitting MS
por: Brenton, J. Nicholas, et al.
Publicado: (2019)

Comparison of Pharmacological Therapies in Relapse Rates in Patients With Relapsing-Remitting Multiple Sclerosis
por: Etta, Indu, et al.
Publicado: (2023)

Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study
por: Zivadinov, Robert, et al.
Publicado: (2013)

Functional cortical changes in relapsing–remitting multiple sclerosis at amplitude configuration: a resting-state fMRI study
por: Liu, Heng, et al.
Publicado: (2016)

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
por: Tenorio-Laranga, Jofre, et al.
Publicado: (2010)

Varicella Zoster Virus and Relapsing Remitting Multiple Sclerosis
por: Sotelo, Julio, et al.
Publicado: (2011)

Disease-modifying therapies in relapsing–remitting multiple sclerosis
por: González-Andrade, Fabricio, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9qqpsd9o9hkg53477q6prttgus